IL6 and neoplasm: The activation of the complement system has become a mediator in anti-tumor treatment, which also increases the secondary inflammatory mediators, such as cytokines IL-1β, IL-6, IL-10, TNF-α, and G-CSF, leukotrienes, thromboxane, prostaglandins, histamine, and coagulation factors (23, 24).